subject area of
- <p>Real-life effectiveness of indacaterol–glycopyrronium after switching from tiotropium or salmeterol/fluticasone therapy in patients with symptomatic COPD: the POWER study</p> Journal Articles
- A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study). Journal Articles
- A systematic review of adverse drug events associated with administration of common asthma medications in children Journal Articles
- Acute asthma intervention: Insights from the STAY study Journal Articles
- Antiinflammatory Effects of Long-Acting β 2 -Agonists in Patients With Asthma Journal Articles
- Are inhaled longacting β2 agonists detrimental to asthma? Journal Articles
- Asthma maintenance and reliever therapy Journal Articles
- Chronic β2-adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca2+-ATPase protein and activity Journal Articles
- Comparison of vilanterol, a novel long-acting beta2 agonist, with placebo and a salmeterol reference arm in asthma uncontrolled by inhaled corticosteroids Journal Articles
- Coronary artery wall shear stress is associated with endothelial dysfunction and expansive arterial remodelling in patients with coronary artery disease Journal Articles
- Coronary β2-adrenoreceptors mediate endothelium-dependent vasoreactivity in humans: novel insights from an in vivo intravascular ultrasound study Journal Articles
- Cost Effectiveness of Leukotriene Receptor Antagonists versus Inhaled Corticosteroids for Initial Asthma Controller Therapy Journal Articles
- Cost Effectiveness of Leukotriene Receptor Antagonists versus Long-Acting Beta-2 Agonists as Add-On Therapy to Inhaled Corticosteroids for Asthma Journal Articles
- Dose-dependent anti-inflammatory effect of inhaled mometasone furoate/formoterol in subjects with asthma Journal Articles
- Dose-finding evaluation of once-daily treatment with olodaterol, a novel long-acting β2-agonist, in patients with asthma: results of a parallel-group study and a crossover study Journal Articles
- Effect of Roflumilast and Inhaled Corticosteroid/Long-Acting β2-Agonist on Chronic Obstructive Pulmonary Disease Exacerbations (RE2SPOND). A Randomized Clinical Trial Journal Articles
- Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β<sub>2</sub>-agonist fixed-dose combination: RE<sup>2</sup>SPOND rationale and study design Journal Articles
- Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatment Journal Articles
- Fluticasone Furoate–Vilanterol 100-25 mcg Compared with Fluticasone Furoate 100 mcg in Asthma: A Randomized Trial Journal Articles
- Formoterol as reliever medication in asthma: a post-hoc analysis of the subgroup of the RELIEF study in East Asia Journal Articles
- Inhaled Reliever Therapies for Asthma: A Systematic Review and Meta-Analysis. Journal Articles
- Intramuscular β2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury Journal Articles
- Long-Acting β2-Agonist Step-off in Patients With Controlled Asthma Journal Articles
- Once daily long-acting beta2-agonists and long-acting muscarinic antagonists in a combined inhaler versus placebo for chronic obstructive pulmonary disease Journal Articles
- Overall asthma control achieved with budesonide/formoterol maintenance and reliever therapy for patients on different treatment steps Journal Articles
- Potentiation of long-acting β2-agonist and glucocorticoid responses in human airway epithelial cells by modulation of intracellular cAMP Journal Articles
- Prolonged bronchoprotection against inhaled methacholine by inhaled BI 1744, a long-acting β2-agonist, in patients with mild asthma Journal Articles
- Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events Journal Articles
- Safety of formoterol in asthma clinical trials: an update Journal Articles
- Safety of long‑acting β2‑agonists: a little bit of history. Dr. Paul O’Byrne in an interview with Dr. Roman Jaeschke: part 1 Journal Articles
- Safety of long‑acting ß2‑agonists: current state of knowledge. Dr. Paul O’Byrne in an interview with Dr. Roman Jaeschke: part 2 Journal Articles
- The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK Journal Articles
- The paradoxes of asthma management: time for a new approach? Journal Articles
- Therapeutic strategies to reduce asthma exacerbations Journal Articles
- Triple vs Dual Inhaler Therapy and Asthma Outcomes in Moderate to Severe Asthma Journal Articles
- β<sub>2</sub>-Agonists for Asthma: The Pediatric Perspective Journal Articles
- β2 Déjà Vu Journal Articles